Triggering receptor expressed on myeloid cells-1 as pediatric sepsis biomarker

SUMMARY OBJECTIVE: Triggering receptor expressed on myeloid cells-1 concentration can be used as a predictive, diagnostic, and prognostic marker in patients with sepsis. The objective of this study was to determine the validity of triggering receptor expressed on myeloid cells-1 levels as a biomarker of sepsis in pediatric patients. METHODS: This was an integrative literature review. PubMed, ScienceDirect, LILACS, MEDLINE, and VHL databases were searched for papers published between 2015 and 2020, using the keywords triggering receptor expressed on myeloid cells-1, sepsis, and child. RESULTS: The review included ten studies, of which four used triggering receptor expressed on myeloid cells-1 as a predictive biomarker; four, as a diagnostic biomarker; and two, as a prognostic biomarker. A total of 1,409 and 1,628 patients were included in primary and review studies, respectively. There was a predominance of significant results for the validity of triggering receptor expressed on myeloid cells-1 levels in the prediction, diagnosis, and prognosis of sepsis in pediatric patients. CONCLUSIONS: Triggering receptor expressed on myeloid cells-1 is a valid predictive, diagnostic, and prognostic biomarker of sepsis with good sensitivity and specificity in the pediatric population.

Bibliographic Details

Main Authors:	Cabral,João Victor, Silveira,Maria Mariana Barros Melo da, Xavier,Amanda Tavares, Assunção,Norma de, Sobral Filho,Dário Celestino, Oliveira,Dinaldo Cavalcanti de
Format:	Digital revista
Language:	English
Published:	Associação Médica Brasileira 2021
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000400449
Tags:	Add Tag No Tags, Be the first to tag this record!